Friday, 23 October 2026
ai3Bio Secures $48M to Advance Immune Reset
Exam Preps

ai3Bio Secures $48M to Advance Immune Reset

ai3Bio raised $48 million Series A to build its immune-reset platform, a therapy that clears disease-driving cells but may also…

By Sintya Dewi  •  05/10/2026
Sanofi invests $1 billion to boost Regeneron partnership and next-gen
Study Plans

Sanofi invests $1 billion to boost Regeneron partnership and next-gen

Sanofi invests $1 billion to deepen Regeneron partnership, accelerating four next-gen antibody treatments inspired by Dupixent’s €15.7 billion success.

By Sintya Dewi  •  02/10/2026